GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Pharma dose CMOs face growth slowdown, but opportunities lie ahead, says GlobalData

Contract manufacturing revenues in the pharmaceutical finished dose sector witnessed a significant slowdown over the past financial year. Challenging market conditions, driven by drug pricing pressures, regulatory shifts, and geopolitical tensions, have reshaped the landscape, offering both hurdles and opportunities for contract manufacturing organizations (CMOs) to adapt and innovate amidst global generic shortages, reveals GlobalData, […]
Read more

Biologic therapies mark progress in severe asthma treatment and remission potential, says GlobalData

Biologic therapies are revolutionizing severe asthma management by targeting specific inflammatory pathways, shifting care from symptom control to potential remission. Real-world evidence underscores their efficacy across diverse patient profiles, including those with complex asthma cases. However, barriers such as cost and accessibility persist, highlighting the urgent need for equitable healthcare solutions to ensure widespread adoption […]
Read more

Arteriotomy closure devices market to reach $873 million by 2033, forecasts GlobalData

The rise in cardiovascular diseases globally has resulted in a higher number of interventional procedures, necessitating the use of arteriotomy closure devices. Arteriotomy closure devices are essential in managing access sites after procedures such as angiography or vascular interventions. Valued at $641 million in 2024, the arteriotomy closure devices market is projected to reach sales […]
Read more

Digital transformation to help accelerate drug development and discovery process, says GlobalData

Ever increasing drug discovery and development timelines is a multiscale issue causing delays in patient access to medicines and increasing costs for pharmaceutical companies. Digital transformation could streamline the process, accelerate innovation, and improve efficiency, according to a survey conducted by GlobalData, a leading data and analytics company. In a recent GlobalData’s survey, “Digital Transformation […]
Read more

AI regulation future in US remains uncertain, says GlobalData

In November 2024, Donald Trump was re-elected as President of the US, with Elon Musk appointed to lead the newly established Department of Efficiency. Musk’s role focuses on streamlining government processes and integrating advanced technologies, a development that marks a significant shift in the regulatory landscape for artificial intelligence (AI) and other emerging technologies. However, […]
Read more

3D secure patents surge highlights banking sector focus on digital security, says GlobalData

As digital payments continue to rise worldwide, the banking industry is prioritizing advanced security technologies to combat the rising online threats. Central to this shift is 3D secure transaction technology. Against this backdrop, the patent filings for 3D secure transactions have risen significantly from 4,603 in 2022 to 8,172 in 2023,  demonstrating the industry’s commitment […]
Read more

Premier League clubs banning associated party transactions to change football league’s sponsorship landscape, says GlobalData

Following the news that Premier League teams have banned associated party transactions; Conrad Wiacek, Head of Sport Analysis at GlobalData, a leading data and analytics company, offers his view: “The decision by Premier League clubs to ban associated party transactions (APT) will be felt by several clubs across the football league. Premier League teams generate […]
Read more

RFK Jr.’s appointment as US HHS Secretary to reshape regulatory and market landscape of medical devices, says GlobalData

The appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services (HHS) has raised significant discussion in the healthcare sector. Healthcare officials have voiced concerns, particularly regarding Kennedy’s history of spreading misinformation and his controversial stance on vaccines. He may advocate for greater scrutiny of medical device approvals, reflecting his general skepticism […]
Read more
1 96 97 98 99 100 775